Amgen (AMGN) adjusted earnings per share of $1.12 for the first quarter of 2008, an increase of 4 % compared to $1.08 for the first quarter of 2007. Adjusted net income decreased 4 % to $1.218 billion in the first quarter of 2008 compared to $1.270 billion in the first quarter of 2007.
Amgen’s revenue decreased 2% during the first quarter of 2008 to $3,613 million versus $3,687 million in the first quarter of 2007.
Worldwide sales of Aranesp decreased 25% to $761 million in the first quarter of 2008. Sales of EPOGEN decreased 11% to $554 million.
Sales of Enbrel increased 30% in the first quarter to $951 million. Worldwide sales of Sensipar increased 27 % to $133 million.
The company guided for GAAP EPS for the year to be in a range of $3.66 to $4.01.
Douglas A. McIntyre
In 20 Years, I Haven’t Seen A Cash Back Card This Good
Credit card companies are at war, handing out free rewards and benefits to win the best customers. A good cash back card can be worth thousands of dollars a year in free money, not to mention other perks like travel, insurance, and access to fancy lounges. Our top pick today has pays up to 5% cash back, a $200 bonus on top, and $0 annual fee. Click here to apply before they stop offering rewards this generous.
Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.